Glucocorticoid maintenance therapy and severe infectious complications in ANCA-associated vasculitis: a retrospective analysis
Rheumatology International · 2021-02 · 41 (2) · 431-438
DOI: 10.1007/s00296-020-04752-9 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Rheumatology International, online erschienen am 22.11.2020. Verfasst von Claudius Speer und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nephrology, University of Heidelberg, INF 162, 69120, Heidelberg, Germany. Claudius.Speer@med.uni-heidelberg.de. Die Arbeit wurde bisher 24-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Medizinische Fakultät Heidelberg der Universität Heidelberg.
Abstract (Originalsprache)
To study the impact of glucocorticoid maintenance dose and treatment duration on outcomes in patients with AAV (ANCA-associated vasculitis) with emphasis on infectious complications. A total of 130 AAV patients from two German vasculitis centers diagnosed between August 2004 and January 2019 treated with cyclophosphamide and glucocorticoids for induction therapy and glucocorticoids for maintenance therapy were retrospectively enrolled. We investigated the influence of glucocorticoid maintenance therapy on patient survival, time to relapse, kidney function, infectious complications and irreversible physical damage. The patients were divided into the following groups: patients treated according to the predefined reduction scheme (< 7.5 mg) or patients treated with glucocorticoids ≥ 7.5 mg after 6 months. Compared to patients receiving < 7.5 mg glucocorticoids after 6 months, patients receiving $$\ge $$ ≥ 7.5 mg had an increased rate of infectious episodes per patient (1.7 vs. 0.6; p < 0.001), including urinary tract infection ( p = 0.007), pneumonia ( p = 0.003), opportunistic pneumonia ( p = 0.022) and sepsis ( p = 0.008). Especially pneumonia during the first 24 months after disease onset [hazard ratio, 3.0 (95% CI 1.5 − 6.1)] led to more deaths from infection ( p = 0.034). Glucocorticoid maintenance therapy after 6 months had no impact on relapse rate or patient survival and decline in kidney function was comparable. Glucocorticoid maintenance therapy with $$\ge $$ ≥ 7.5 mg after 6 months is associated with more severe infectious complications leading to an increased frequency of deaths from infection. Glucocorticoid maintenance therapy has no effect on time to relapse or patient survival and should therefore be critically revised throughout the aftercare of AAV patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Nephrology, University of Heidelberg, INF 162, 69120, Heidelberg, Germany. Claudius.Speer@med.uni-heidelberg.de.
- Department of Nephrology, University of Heidelberg, INF 162, 69120, Heidelberg, Germany.
- Department of Internal Medicine A, Clinical Center Ludwigshafen, Ludwigshafen, Germany.
Förderung
- Medizinische Fakultät Heidelberg der Universität Heidelberg
Zitieren
APA
Speer, C., Altenmüller-Walther, C., Splitthoff, J., Nusshag, C., Kälble, F., Reichel, P., Morath, C., Zeier, M., Bergner, R., & Schaier, M. (2021). Glucocorticoid maintenance therapy and severe infectious complications in ANCA-associated vasculitis: a retrospective analysis. Rheumatology International, 41(2), 431-438. https://doi.org/10.1007/s00296-020-04752-9
Vancouver
Speer C, Altenmüller-Walther C, Splitthoff J, Nusshag C, Kälble F, Reichel P, et al. Glucocorticoid maintenance therapy and severe infectious complications in ANCA-associated vasculitis: a retrospective analysis. Rheumatology International. 2021;41(2):431-438. doi:10.1007/s00296-020-04752-9
BibTeX
@article{Speer2021,
author = {Speer, Claudius and Altenmüller-Walther, Christine and Splitthoff, Jan and Nusshag, Christian and Kälble, Florian and Reichel, Paula and Morath, Christian and Zeier, Martin and Bergner, Raoul and Schaier, Matthias},
title = {Glucocorticoid maintenance therapy and severe infectious complications in ANCA-associated vasculitis: a retrospective analysis},
journal = {Rheumatology International},
year = {2021},
volume = {41},
number = {2},
pages = {431--438},
doi = {10.1007/s00296-020-04752-9}
}
EUVIMED